ArticleCancer immunology, immunotherapy : CII2019

Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study.

Maria Pia Pistillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.